HUT60506A - Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations - Google Patents

Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations

Info

Publication number
HUT60506A
HUT60506A HU9201659A HU165990A HUT60506A HU T60506 A HUT60506 A HU T60506A HU 9201659 A HU9201659 A HU 9201659A HU 165990 A HU165990 A HU 165990A HU T60506 A HUT60506 A HU T60506A
Authority
HU
Hungary
Prior art keywords
replicable
antiviral
producing non
recombinant retrovirus
immunogenic preparations
Prior art date
Application number
HU9201659A
Other languages
English (en)
Other versions
HU9201659D0 (en
Inventor
Omar K Haffar
Shiu-Lok Hu
Allen W Senear
Bruce M Travis
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of HU9201659D0 publication Critical patent/HU9201659D0/hu
Publication of HUT60506A publication Critical patent/HUT60506A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9201659A 1989-11-20 1990-11-20 Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations HUT60506A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (2)

Publication Number Publication Date
HU9201659D0 HU9201659D0 (en) 1992-08-28
HUT60506A true HUT60506A (en) 1992-09-28

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9201659A HUT60506A (en) 1989-11-20 1990-11-20 Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations

Country Status (14)

Country Link
EP (1) EP0502105A4 (hu)
JP (1) JPH05503629A (hu)
KR (1) KR920703639A (hu)
AU (1) AU636944B2 (hu)
CA (1) CA2068713A1 (hu)
ES (1) ES2052478T1 (hu)
FI (1) FI922277A0 (hu)
GR (1) GR930300005T1 (hu)
HU (1) HUT60506A (hu)
NO (1) NO921969L (hu)
OA (1) OA09698A (hu)
TW (1) TW216446B (hu)
WO (1) WO1991007425A1 (hu)
ZA (1) ZA909302B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288304A3 (en) * 1989-06-01 2006-04-05 Applied Biotechnology, Inc. Self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
WO1993009238A1 (en) * 1991-11-08 1993-05-13 The Upjohn Company Feline leukemia virus vaccines
AU2462392A (en) * 1992-04-14 1993-11-18 British Biotech Pharmaceuticals Limited Induction of CTL responses
ATE420193T1 (de) * 1993-01-26 2009-01-15 Univ Pennsylvania Zusammensetzung zur verabreichung genetischen materials
ATE302854T1 (de) 1993-01-26 2005-09-15 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
CN1185811A (zh) * 1995-03-31 1998-06-24 H·沃尔夫 依赖于逆转录病毒样颗粒的抗原呈递系统
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
AU1194802A (en) 2000-03-02 2001-12-11 Univ Emory DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
AU2002252199B2 (en) * 2001-03-08 2008-01-03 Emory University MVA expressing modified HIV envelope, GAG, and POL genes
CA2452015C (en) 2001-07-05 2012-07-03 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
PT2694101T (pt) 2011-04-06 2016-12-19 Université Paris Descartes Composições farmacêutivas para prevenção e/ou tratamento de doença por vih em seres humanos
ES2937963T3 (es) 2015-07-21 2023-04-03 Modernatx Inc Vacunas de enfermedad infecciosa
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
EP3938379A4 (en) * 2019-03-15 2023-02-22 ModernaTX, Inc. HIV RNA VACCINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
WO1991007425A1 (en) 1991-05-30
JPH05503629A (ja) 1993-06-17
KR920703639A (ko) 1992-12-18
EP0502105A1 (en) 1992-09-09
NO921969L (no) 1992-06-26
TW216446B (hu) 1993-11-21
FI922277A (fi) 1992-05-19
GR930300005T1 (hu) 1993-04-28
CA2068713A1 (en) 1991-05-21
OA09698A (en) 1993-08-30
HU9201659D0 (en) 1992-08-28
ES2052478T1 (es) 1994-07-16
AU6905591A (en) 1991-06-13
NO921969D0 (no) 1992-05-19
AU636944B2 (en) 1993-05-13
ZA909302B (en) 1991-09-25
FI922277A0 (fi) 1992-05-19
EP0502105A4 (en) 1993-02-24

Similar Documents

Publication Publication Date Title
HUT60506A (en) Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations
HU908296D0 (en) Process for the production of antiviral polypeptides and medical preparations containing them
PT86318A (en) Process for the preparation of immunogenic proteins
AU584289B2 (en) Detergent powders and process for their preparation
AU602932B2 (en) Detergent powders and processes for preparing them
AU3401689A (en) Detergent powders and process for preparing them
AU624436B2 (en) Albumin preparation and process for preparing the same
IL82235A (en) Immunogen complexes, their preparation and vaccines comprising them
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
AU590346B2 (en) Process for the preparation of halogenated (2,2)- paracyclophanes and mixtures of resultant halogenated (2,2)-paracyclophanes
AU581810B2 (en) Detergent powders and processes for preparing them
AU3149889A (en) Detergent powders and process for preparing them
BG51041A3 (en) Process for the preparation of (s)- alpha- ethyl- 2- oxo- 1- pyrrolidineacetamide
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
NZ239948A (en) Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
EP0416402A3 (en) Cleavable surfactants, process for their preparation and use
IL89430A0 (en) Process for the preparation of 4,4'-dibromodiphenyl
AU1374088A (en) Beauty preparations having anti-fading effect and a process for preparing the same
PH25323A (en) Sperical fine particulate pigment, process for preparing the same
DK162889A (da) Fremgangsmaade til rensning af dipeptider
AU2738088A (en) Soluble recombinant fce-receptor, the preparation and the use thereof
ZA901718B (en) Sdk peptides,a preparation process of the same and therapeutic compositions containing them
EP0344112A3 (en) Substituted bisacyloxynaphthacenes, and process for the preparation of tetrathiotetracenes
HU896683D0 (en) Process for the preparation of new therapeutical preparations
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal